Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹2,438.20
2.20 (0.09%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹41.30K Cr
MID CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
39.9
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹2,088.1+16.8%
52W High₹3,237.5-24.7%
Current Price
₹2,438.20
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,950.56
Upper Circuit₹2,925.84
Reference Price
₹2,438.20
Investment Checklist
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹2433.7
Rounding Bottom on 1D (BREAKOUT CONFIRMED) — target ₹2500.6
Volume divergence: Bearish (price up, volume down)
News: Volumes soar at Glaxosmithkline Pharmaceuticals Ltd counter...
20/50 Bullish Cross detected 4 day(s) ago
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
41%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
2364.72
EMA50
2327.27
EMA200
2454.64
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows4
Lower Highs4
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹2463.23
₹2504.18
₹2565.57
₹2602.60
₹2645.90
Support (Below)
₹2407.07
₹2343.40
₹2304.00
₹2261.80
₹2216.00
Volume Analysis
TrendDECREASING
Change-51.30%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Recent MA Crossovers
20/50 Bullish Cross
4 days ago
BUY
Stop Loss Levels
Fixed Risk
1% Risk₹2413.82
3% Risk₹2365.05
5% Risk₹2316.29
7% Risk (Custom)
₹2267.53Technical Levels
1x ATR (Volatility)₹2382.36
2x ATR (Swing)₹2326.52
3x ATR (Trend)₹2270.68
Immediate Support₹2407.07
Moving Averages
EMA 9 (Short-term)₹2410.11
EMA 20 (Medium-term)₹2364.72
EMA 50 (Trend)₹2327.27
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹949.4 Cr | ₹951.2 Cr | ₹805.2 Cr | ₹1,041.3 Cr |
| Net Profit | ₹229.9 Cr | ₹262.9 Cr | ₹205 Cr | ₹295.6 Cr |
| EPS | ₹13.57 | — | ₹12.10 | ₹17.45 |
| Operating Profit | ₹327 Cr | ₹373.9 Cr | ₹294.9 Cr | ₹421.4 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| GlaxoSmithKline Pharmaceuticals Limited | ₹2,438.20 | -0.09% | 39.9 | ₹41.30K Cr mid Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 29 May 2026 | Dividend - Rs 57 Per Share | DIVIDEND |
| 30 May 2025 | Dividend - Rs 42 Per Share | DIVIDEND |
| 07 Nov 2024 | Interim Dividend - Rs 12 Per Share | INTERIM_DIVIDEND |
| 31 May 2024 | Dividend - Rs 32 Per Share | DIVIDEND |
| 30 Jun 2023 | Dividend - Rs 32 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for GLAXO
View AllNEWS
positive
Business Standard - Markets 5d ago
Volumes soar at Glaxosmithkline Pharmaceuticals Ltd counter
Glaxosmithkline Pharmaceuticals Ltd recorded volume of 1.82 lakh shares by 10:46 IST on BSE, a 17.18 times surge over two-week average daily volume of 10602 shares
BSEGLAXOFinancial ServicesHealthcare
positive
NDTV Profit 45d ago
Bajaj Auto, Bank Of India, Glaxo, ICICI Lombard, Torrent Pharma, Uno Minda: Dividend Record Date: Last Day To Buy Shares To Qualify
Dividend Record Date: Last Day To Buy Shares To Qualify
AUTOIETFBAJAJ-AUTOBANKBETFBANKIETFBANKINDIADIVIDENDFINIETFGLAXOICICIBANKICICIGIMINDACORPPSUBNKIETFPVTBANIETFUNOMINDAAutomobile and Auto ComponentsFinancial Services
negative
ET Markets - Industry 53d ago
GSK's Calpol a well-known trademark: High Court
The Delhi High Court has recognized GlaxoSmithKline Pharmaceuticals' pain and fever medicine, Calpol, as a well-known trademark. This designation acknowledges Calpol's extensive recognition in India since 1991. The court found that consumers associate the brand exclusively with GSK due to its long and continuous use.
GLAXOHealthcare